Type of opioids injected: Does it matter? A multicentric cross-sectional study of people who inject drugs

Drug and Alcohol Review

Volumn 34, Issue 1, 2015, Pages 97-104

  Ambekar, Atul ^a   Rao, Ravindra ^a   Mishra, Ashwani Kumar ^a   Agrawal, Alok ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Drug use pattern; Intravenous drug abuse; Opioid use disorder; Pharmaceutical opioid

Indexed keywords

NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DRUG ABUSE; HUMAN; INDIA; MALE; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; OPIOID-RELATED DISORDERS; QUESTIONNAIRE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; CROSS-SECTIONAL STUDIES; HUMANS; INDIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEEDLE SHARING; OPIOID-RELATED DISORDERS; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 84921278244     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1111/dar.12208     Document Type: Article

References (32)

1. United Nations Office on Drugs and Crime. World Drug Report. Vienna: United Nations Office on Drugs and Crime, UNODC, 2013.
2. Mathers BM, Degenhardt L, Phillips B, etal. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008;372:1733-1745.
3. International Narcotics Control Board. Report of the International Narcotics Control Board for 2011. New York: United Nations, 2012.
4. Larance B, Ambekar A, Azim T, etal. The availability, diversion and injection of pharmaceutical opioids in South Asia. Drug Alcohol Rev 2011;30:246-254.
5. Kumar MS. Rapid Situation and Response Assessment (RSRA) of HIV/AIDS related risk behaviours, adverse health consequences, knowledge and attitudes relating to HIV/AIDS amongst drug users and their regular sex partners in Bangladesh, Bhutan, India, Nepal and Sri Lanka. New Delhi: United Nations Office on Drugs and Crime, Regional Office for South Asia, 2008.
6. Department of AIDS Control. Annual report 2011-2012. New Delhi: Department of AIDS Control, Ministry of Health and Family Welfare, Government of India, 2012. Available at: http://aidsdatahub.org/en/india-reference-library/item/23889-annual-report-2011-12-national-aids-control-organisation-india-department-of-aids-control-ministry-of-health-family-welfare-2012 (accessed August 2013).
7. Kumar MS. Injecting drug use and HIV/AIDS in India: an emerging concern. New Delhi: UNODC, Regional Office for South Asia and Ministry of Social Justice and Empowerment, Government of India, 2004.
8. Ambekar A, Tripathi B. Size estimation of injecting drug use in Punjab and Haryana. New Delhi: Joint UN Programme on HIV/AIDS (UNAIDS), 2008.
9. Sarna A, Tun W, Bhattacharya A, Lewis D, Singh YS, Apicella L. Assessment of unsafe injection practices and sexual behaviors among male injecting drug users in two urban cities of India using respondent driven sampling. Southeast Asian J Trop Med Public Health 2012;43:652-667.
10. Wu L, Woody G, Yang C, Blazer D. How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Addict Med 2011;5:28-35.
11. Wu L, Woody G, Yang C, Mannelli P, Blazer D. Differences in onset and abuse/dependence episodes between prescription opioids and heroin: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Subst Abuse Rehabil 2011;2:77-88.
12. Pollini R, Banta-Green C, Ceuvas-Mota J, Metzner M, Teshale E, Garfein R. Problematic use of prescription-type opioids prior to heroin use among young heroin injectors. Subst Abuse Rehabil 2011;2:173-180.
13. Nielsen S, Bruno R, Lintzeris N, Fischer J, Carruthers S, Stoove M. Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia? Drug Alcohol Rev 2011;30:291-299.
14. Moore BA, Fiellin DA, Barry DT, etal. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med 2007;22:527-530.
15. Ambekar A. Association of drug use pattern with vulnerability and service uptake among injecting drug users. New Delhi: United Nations Office on Drugs and Crime, Regional Office for South Asia, 2012.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author, 2000.
17. Werb D, Hayashi K, Fairbairn N, etal. Drug use patterns among Thai illicit drug injectors amidst increased police presence. Subst Abuse Treat Prev Policy 2009;4:16.
18. Diaz T, Chu S, Byers R, etal. The type of drugs used by HIV infected injection drug users in a multi-state surveillance project: implications for intervention. Am J Public Health 1994;84:1971-1975.
19. Hayashi K, Suwannawong P, Ti L, Kaplan K, Wood E, Kerr T. High rates of midazolam injection and associated harms in Bangkok, Thailand. Addiction 2013;108:944-952.
20. National Centre for AIDS and STD Control. NCASC and ASHA Project 2011 Integrated Biological and Behavioral Surveillance (IBBS) survey among injecting drug users in Kathmandu and Pokhara Valley, Nepal, Round V-2011. Nepal: Author, 2011.
21. Azim T, Chowdhury E, Reza M, etal. Prevalence of infections, HIV risk behaviors and factors associated with HIV infection among male injecting drug users attending a needle/syringe exchange program in Dhaka, Bangladesh. Subst Use Misuse 2008;43:2124-2144.
22. United Nations Office on Drugs and Crime, Country Office Pakistan, and Ministry of Narcotics Control, Pakistan Bureau of Statistics, Government of Pakistan. Drug use in Pakistan 2013, technical summary report. Pakistan: Author, 2013.
23. McCabe SE, Cranford JA, Boyd CJ, Teter CJ. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav 2007;32:562-575.
24. Subramaniam G, Stitzer M. Clinical characteristics of treatment-seeking prescription opioid versus heroin using adolescents with opioid use disorder. Drug Alcohol Depend 2009;101:13-19.
25. Yoe AKS, Chan C, Chia K. Complications relating to intravenous buprenorphine abuse: a single institution case series. Ann Acad Med Singapore 2006;35:487-491.
26. Panda S, Chatterjee A, Bhattacharya SK. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks. Int J STD AIDS 1998;9:214-218.
27. Panda S (2006) Drug use in the north eastern states of India: UNODC Regional Office for South Asia and the Ministry of Social Justice and Empowerment, Government of India.
28. Goldstein G. Pentazocine. Drug Alcohol Depend 1985;14:313-323.
29. Beyrer C, Malinowska-Sempruch K, Kamarulzaman A, Kazatchkine M, Sidibe M, Strathdee SA. Time to act: a call for comprehensive responses to HIV in people who use drugs. Lancet 2010;376:551-563.
30. Mathers BM, Degenhardt L, Ali H, etal. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet 2010;375:1014-1028.
31. Rao R, Agrawal A, Kishore K, Ambekar A. Delivery models of opioid agonist maintenance treatment in South Asia: a good beginning. Bull World Health Organ 2013;91:150-153.
32. World Health Organisation. WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users-2012 revision. Geneva: Author, 2012.